Back to 
FARALLON CAPITAL MANAGEMENT, L.L.C.
FARALLON CAPITAL MANAGEMENT, L.L.C.
SYRE3 quarters
Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in Spyre Therapeutics, Inc
FARALLON CAPITAL MANAGEMENT, L.L.C. previously held 0 shares of SYRE (Spyre Therapeutics, Inc), worth $0 as of 2024-Q3.
Final Value
$0
Final Shares
0
Total Value Change
-$17.7M
Total Shares Change
-466,000
Quarter-by-Quarter History
Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP